RGRamazan Maksudovich Gabibullaev

Ramazan Maksudovich Gabibullaev

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ramazan Maksudovich Gabibullaev has a total of 77 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Phenotypic variants of Х-linked adrenoleukodystrophy: аcase series

    by L. V. Savelyeva, S. I. Motkova, E. V. Morozova, A. N. Zvyagintseva, D. V. Ivanova, R. M. Gabibullaev, A. S. Arustamyan, Л. В. Савельева, С. И. Моткова, Е. В. Морозова, et al.

    Background. X-linked adrenoleukodystrophy is an inherited disorder caused by pathogenic variants in the ABCD1 gene and characterized by marked clinical heterogeneity. The spectrum of disease manifestations includes involvement of the adrenal cortex and central nervous system, while the age at onset, sequence of clinical manifestations, and rate of disease progression may vary considerably even among patients sharing the same molecular genetic basis of the disease. Such phenotypic variability poses substantial challenges to the timely diagnosis of X-linked adrenoleukodystrophy, particularly in cases where primary adrenal insufficiency remains the only clinical manifestation for an extended period. This article presents a case series of three patients with genetically confirmed X-linked adrenoleukodystrophy and pathogenic variants identified in the ABCD1 gene. Despite the common molecular genetic basis of the disease, the clinical manifestations differed substantially, ranging from isolated primary adrenal insufficiency to combined endocrine involvement accompanied by neurological manifestations. In all three cases, the first manifestations of the disease occurred during childhood. However, a considerable delay was observed between the onset of clinical symptoms and establishment of the definitive diagnosis, reaching approximately 10 years in some cases. Delayed diagnosis was accompanied by the late initiation of adequate replacement therapy; poor adherence to prescribed treatment represented an additional factor potentially contributing to an unfavorable disease course. Results. The presented clinical cases demonstrate the diagnostic challenges associated with X-linked adrenoleukodystrophy and emphasize the need to consider this disorder in the differential diagnosis of male patients with primary adrenal insufficiency, particularly when it develops during childhood or young adulthood and no apparent cause of adrenal dysfunction is identified. Endocrine manifestations may precede the onset of neurological symptoms and may therefore provide an opportunity for earlier diagnosis and appropriate long-term follow-up. Timely molecular genetic confirmation is important not only for establishing the diagnosis of X-linked adrenoleukodystrophy but also for determining subsequent surveillance strategies and providing genetic counseling to affected families. Conclusion. Thus, increased clinical awareness of X-linked adrenoleukodystrophy in young male patients with primary adrenal insufficiency, timely molecular genetic testing, adequate replacement therapy, assessment of treatment adherence, multidisciplinary management, and regular long-term follow-up are essential components of care for this patient population. This case series further illustrates the pronounced phenotypic variability of X-linked adrenoleukodystrophy and highlights the clinical importance of early recognition of endocrine manifestations for timely diagnosis and preservation of patients’ quality of life.

  • Open Access

    Primary aldosteronism as an independent factor of kidney damage. Potential therapeutic strategies and research prospects

    by N. M. Platonova, R. M. Gabibullaev, D. R. Makhachev, A. A.-Yu. Dotduev, D. A. Polyakova, D. A. Mukhina, Z. A. Belbekova, V. V. Mayer, A. S. Khadziev, E. A. Troshina

    Primary aldosteronism (PA) is the most common curable cause of secondary hypertension and an independent risk factor for chronic kidney disease (CKD). This review focuses on the pathophysiological mechanisms of aldosterone-induced renal injury, including mineralocorticoid receptor activation, nongenomic signaling via GPER, oxidative stress, and the upregulation of profibrotic and inflammatory mediators such as TGF-β1, NF-κB, and NLRP3. Chronic aldosterone excess leads to podocyte injury, microvascular dysfunction, and interstitial fibrosis, resulting in decreased glomerular filtration rate and CKD progression. Genetic mutations (KCNJ5, ATP1A1, CACNA1D) and tubular stress biomarkers (L-FABP, KIM-1, microalbuminuria) are discussed as key factors of early nephron injury. Comparative clinical data show that adrenalectomy provides superior nephroprotection compared to pharmacological blockade, while long-term therapy with mineralocorticoid receptor antagonists requires careful renal monitoring. Emerging therapeutic strategies, including nonsteroidal MR antagonists and aldosterone synthase inhibitors (baxdrostat), offer new prospects for targeted nephroprotection. By integrating molecular and clinical evidence, this review highlights the central role of aldosterone in renal pathology and emphasizes early detection and personalized treatment approaches to prevent CKD progression in patients with PA.

  • Open Access

    Diagnostic challenges of primary aldosteronism in a patient with chronic kidney disease and resistant arterial hypertension: a case report

    by R. M. Gabibullaev, D. R. Makhachev, G. S. Bagieva, L. V. Savelieva, S. A. Ibragimova, L. S. Urusova, N. V. Latkina, A. A. Udagova, S. M. Gasanova, B. M. Babatova, et al.

    Primary aldosteronism is a common cause of secondary arterial hypertension; however, its recognition may be substantially complicated by concomitant chronic kidney disease. Altered regulation of the renin-angiotensin- aldosterone system (RAAS), the effects of antihypertensive therapy, and the absence of typical laboratory features may create an atypical diagnostic profile and delay diagnosis. This article presents a clinical case of primary aldosteronism in a young patient with chronic kidney disease and resistant arterial hypertension, characterized by the absence of hypokalemia and by non-suppressed renin at the initial evaluation. After confirmatory testing and withdrawal of therapy affecting the RAAS, adrenalectomy was performed, and morphological and immunohistochemical examination confirmed an aldosterone-producing adenoma. This case illustrates the limitations of standard screening criteria and highlights the need for comprehensive interpretation of clinical, laboratory, and morphological findings when primary aldosteronism is suspected in patients with chronic kidney disease.

  • Molecular Epigenetic Modulation of Immune Tolerance in Graves' Disease: The Role of Short-Chain Fatty Acids in the Regulation of TRAb Synthesis

    by R. M. Gabibullaev, A. A. Udagova, S. A. Ibragimova, L. R. Khorava, V. A. Prokurorova, R. A. Azizova, H. A. Alikhanova, E. I. Merzhoeva, Ya. E. Maltseva, Ya. E. Simakova, et al.

    Graves’ disease is a systemic autoimmune process characterized by persistent breakdown of immune tolerance and continued presence of thyrotropin receptor autoantibodies (TRAb), even after radical thyroidectomy. This review examines the role of the “gut–thyroid axis” as a key regulator of systemic immune homeostasis. Particular attention is paid to short-chain fatty acids (SCFAs) — microbial metabolites that act as potent epigenetic modulators. The mechanisms of histone deacetylase (HDAC) inhibition by butyrate and propionate are described in detail, which promote stabilization of Foxp3 gene expression in regulatory T cells and suppression of B-lymphocyte differentiation factors (AID, Blimp-1). The interplay between intestinal dysbiosis, increased barrier permeability, and uncontrolled autoantibody production is analyzed. In conclusion, prospective targeted therapeutic strategies are discussed, fecal microbiota transplantation (FMT), and the use selective HDAC inhibitors aimed at restoring immune control in refractory forms of the disease.

  • Pathomorphological Aspects of Sarcopenia in Degenerative Spine Diseases: From Muscle Biopsy to Surgical Outcome Prediction

    by Dmitriy Vladimirovich Bulanov, Ilya Sergeevich Morozov, Anton Gerasimovich Nazarenko, Marchel Stepanovich Vetrile, Alexander Alekseevich Kuleshov, Dalgat Makhachev, Ibragim Gasanovich Musapirov, Aslakhan Vetenovich Alirzaev, Rafiga Alieva, Madina Rashidovna Musaeva, et al.

    Sarcopenia in degenerative spine diseases is a key modifiable factor influencing surgical outcomes, complication rates, and the trajectory of postoperative recovery. The paraspinal muscles—particularly the multifidus and erector spinae—play a central role in segmental stabilization and sagittal balance, making their degeneration clinically significant. This review summarizes the pathomorphological features of local sarcopenia, including predominant type II fiber atrophy, myosteatosis, endo- and perimysial fibrosis, denervation–reinnervation changes, reduced capillary density, mitochondrial dysfunction, and impaired proteostasis, all of which contribute to persistent metabolic stress within the muscle tissue. These alterations are reflected in quantitative imaging biomarkers such as proton density fat fraction (PDFF) and multi-echo Dixon sequences, cross-sectional area (CSA/lean-CSA), psoas muscle and multifidus indices (PMI/MFI), as well as CT-based measures of lumbar and paraspinal muscle density. The review discusses the integration of biopsy-derived morphological data with quantitative MRI/CT for noninvasive risk stratification and longitudinal monitoring of “muscle quality” both at the planned levels of fixation and at the upper instrumented vertebra (UIV). Particular attention is given to the association between paraspinal sarcopenia and key surgical complications, including proximal junctional kyphosis/failure (PJK/PJF), cage subsidence, construct instability, delayed rehabilitation, and an increased likelihood of revision surgery. The concept of the “muscle–bone axis,” which links paraspinal muscle status to bone mineral density and microarchitecture, is also examined due to its relevance for selecting fixation levels and implant types. Additional focus is placed on the standardization of quantitative MRI protocols, the use of validated visual grading scales when PDFF/Dixon is not available, and the role of preoperative optimization (nutritional support, correction of deficiencies, resistance training) in mitigating surgical risk. Overall, local sarcopenia is presented as a critical morpho-imaging biomarker that should be systematically incorporated into preoperative planning and postoperative rehabilitation pathways for patients with degenerative spine disorders.

  • Open Access

    Modern criteria for assessing the therapeutic pathomorphosis of synovial sarcoma: clinical significance and outcome prediction

    by D. R. Makhachev, D. V. Bulanov, D. M. Ametov, M. O. Abakarov, A. R. Abacharaeva, P. A. Bagandova, R. M. Gabibullaev, A. D. Dzhanboriev

    Synovial sarcoma is a rare malignant soft tissue tumor characterized by high aggressiveness and a propensity for metastasis. The assessment of therapeutic pathomorphosis plays a crucial role in predicting disease outcomes and selecting the optimal treatment strategy. This article discusses the morphological and molecular characteristics of synovial sarcoma, existing classifications of pathomorphosis, modern assessment methods, and the prognostic significance of pathomorphosis degree. Special attention is given to the impact of various factors on treatment efficacy, the prospects of personalized medicine, and the integration of innovative technologies in the diagnosis and management of this tumor.

  • Open Access

    Pseudomembranous colitis poses a significant challenge, especially among patients with risk factors. A clinical case of severe pseudomembranous colitis: a call for active testing in high-risk patients

    by D. V. Boykova, N. N. Vlasenko, M. E. Zharova, I. O. Ivannikov, M. A. Idrisova, M. P. Kosmina, D. D. Magomedova, F. B. Amrakhova, R. M. Gabibullaev

    Aim. Our research aimed to describe a case of pseudomembranous colitis in a patient with secondary immunodeficiency. This case stresses the crucial importance of heightened awareness among physicians from diverse specialties when managing patients with diarrhea. Methods and material: We analyzed the clinical case of a 52-year-old woman, Ms. T, who had a history of systemic psoriasis and prolonged therapy with systemic steroids. She developed a diarrhea two weeks after receiving antibiotic treatment. Results: Patient T. was admitted to a local hospital with a diagnosis of gastrointestinal infection, but testing for Clostridioides difficile was not performed After receiving symptomatic therapy, the patient was discharged with some improvement in her condition. A day later, the diarrhea recurred. However, the patient refused to be hospitalized again. Within 30 days of staying at home and using only symptomatic therapy, the patient experienced increasing weakness and dyspepsic syndrome, diarrhea persisted up to 20 times a day, which prompted her emergency hospitalization in the gastroenterology department of the Central Clinical Hospital. On admission, her condition was considered as moderately to severe with pronounced protein-energy deficiency, electrolyte disturbances and moderate dehydration. Following a comprehensive differential diagnosis, the patient was diagnosed with severe pseudomembranous colitis. Treatment commenced with targeted antibacterial, symptomatic, and pathogenetic therapies, showing initial positive results. However, severe exhaustion and microbiota translocation resulted in sepsis, prolonging her hospital stay. After a series of therapeutic and rehabilitative interventions, the patient was discharged in a satisfactory condition. Conclusion: This clinical case highlights the importance of routine testing for clostridial infection in patients with diarrhea and risk factors. Such proactive measures could potentially prevent life-threatening complications and reduce hospitalization periods.